NCT06586398View on ClinicalTrials.gov

A Pilot rTMS Trial for Neuropsychiatric Symptoms of Long-COVID

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions
Long Covid-19PASC Post Acute Sequelae of COVID 19Brain FogFatigue
Interventions
DEVICE

rTMS

Participants will be randomized to 15 sessions of double-blind multi-target rTMS treatment (active vs sham) and then will receive only open-label active stimulation for another 15 sessions. Each session will include rTMS to the left dorsolateral prefrontal cortex (DLPFC), followed by rTMS to left primary motor cortex (M1).

Trial Locations (1)

90095

RECRUITING

UCLA Semel Institute, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER